Skip to main content
Top
Published in: Diabetologia 11/2003

01-11-2003 | Article

13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and γ-glutamyl cycle activity in a clonal pancreatic beta-cell line

Authors: L. Brennan, M. Corless, C. Hewage, J. P. G. Malthouse, N. H. McClenaghan, P. R. Flatt, P. Newsholme

Published in: Diabetologia | Issue 11/2003

Login to get access

Abstract

Aims/hypothesis

Pancreatic islet cells and clonal beta-cell lines can metabolise L-glutamine at high rates. The pathway of L-glutamine metabolism has traditionally been described as L-glutamine→L-glutamate→2-oxoglutarate→oxidation in TCA cycle following conversion to pyruvate. Controversially, the metabolism of D-glucose to L-glutamate in beta cells is not widely accepted. However, L-glutamate has been proposed to be a stimulation-secretion coupling factor in glucose-induced insulin secretion. We aimed to investigate the metabolism of glutamine and glucose by using 13C NMR analysis.

Methods

BRIN-BD11 cells were incubated in the presence of 16.7 mmol/l [1-13C]glucose, 2 mmol/l [2-13C]L-glycine or 2 mmol/l [1,2-13C]glutamine in the presence or absence of other amino acids or inhibitors. After an incubation period the cellular metabolites were extracted using a PCA extract procedure. After neutralisation, the extracts were prepared for analysis using 13C-NMR spectroscopy.

Results

Using 13C NMR analysis we have shown that L-glutamine could be metabolised in BRIN-BD11 cells via reactions constituting part of the γ-glutamyl cycle producing glutathione. Moderate or high activities of the enzymes required for these pathways of metabolism including glutaminase, γ-glutamyltransferase and γ-glutamylcysteine synthetase were observed. We additionally report significant D-glucose metabolism to L-glutamate. Addition of the aminotransferase inhibitor, aminooxyacetate, attenuated L-glutamate production from D-glucose.

Conclusion/interpretation

We propose that L-glutamine metabolism is important in the beta cell for generation of stimulus-secretion coupling factors, precursors of glutathione synthesis and for supplying carbon for oxidation in the TCA cycle. D-glucose, under appropriate conditions, can be converted to L-glutamate via an aminotransferase catalysed step.
Literature
1.
go back to reference Newsholme P, Procopio J, Ramos Lima MM, Pithon-Curi TC, Curi R (2003) Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem Funct 21:1–9CrossRefPubMed Newsholme P, Procopio J, Ramos Lima MM, Pithon-Curi TC, Curi R (2003) Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem Funct 21:1–9CrossRefPubMed
2.
go back to reference Malaisse-Lagae F, Sener A, Garcia-Morales P, Valverde I, Malaisse WJ (1982) The stimulus-secretion coupling of amino acid-induced insulin release. Influence of a nonmetabolized analog of leucine on the metabolism of glutamine in pancreatic islets. J Biol Chem 257:3754–3758PubMed Malaisse-Lagae F, Sener A, Garcia-Morales P, Valverde I, Malaisse WJ (1982) The stimulus-secretion coupling of amino acid-induced insulin release. Influence of a nonmetabolized analog of leucine on the metabolism of glutamine in pancreatic islets. J Biol Chem 257:3754–3758PubMed
3.
go back to reference Rasschaert J, Flatt PR, McClenaghan NH, Malaisse WJ (1996) Amino acid oxidation in BRIN-BD11 islet cells. Med Sci Res 24:691–692 Rasschaert J, Flatt PR, McClenaghan NH, Malaisse WJ (1996) Amino acid oxidation in BRIN-BD11 islet cells. Med Sci Res 24:691–692
4.
go back to reference Wollheim CB (2000) Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in Type II diabetes. Diabetologia 43:265–277PubMed Wollheim CB (2000) Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in Type II diabetes. Diabetologia 43:265–277PubMed
5.
go back to reference Maechler P, Wollheim CB (1999) Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402:595–596CrossRefPubMed Maechler P, Wollheim CB (1999) Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402:595–596CrossRefPubMed
6.
go back to reference McClenaghan NH, Barnett CR, O'Harte FPM, Flatt PR (1996) Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic β-cell line. J Endocrinol 15:349–357 McClenaghan NH, Barnett CR, O'Harte FPM, Flatt PR (1996) Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic β-cell line. J Endocrinol 15:349–357
7.
go back to reference MacDonald MJ, Fahien LA (2000) Glutamate is not a messenger in insulin secretion. J Biol Chem 275:34025–34027CrossRefPubMed MacDonald MJ, Fahien LA (2000) Glutamate is not a messenger in insulin secretion. J Biol Chem 275:34025–34027CrossRefPubMed
8.
go back to reference Bertrand G, Ishiyama N, Nenquin M, Ravier MA, Henquin J-C (2002) The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related. J Biol Chem 277:32883–32891CrossRefPubMed Bertrand G, Ishiyama N, Nenquin M, Ravier MA, Henquin J-C (2002) The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related. J Biol Chem 277:32883–32891CrossRefPubMed
9.
go back to reference Sener A, Mercan D, Malaisse WJ (2001): Enzymic activities in two populations of purified rat islet beta-cells. Int J Mol Med 8:285–289PubMed Sener A, Mercan D, Malaisse WJ (2001): Enzymic activities in two populations of purified rat islet beta-cells. Int J Mol Med 8:285–289PubMed
10.
go back to reference Rasschaert J, Flatt PR, Barnett CR, McClenaghan NH, Malaisse WJ (1996) D-glucose metabolism in BRIN-BD11 islet cells. Biochem Mol Med 57:97–105CrossRefPubMed Rasschaert J, Flatt PR, Barnett CR, McClenaghan NH, Malaisse WJ (1996) D-glucose metabolism in BRIN-BD11 islet cells. Biochem Mol Med 57:97–105CrossRefPubMed
11.
go back to reference Prentki M, Renold AE (1983) Neutral amino acid transport in isolated rat pancreatic islets. J Biol Chem 258:14239–14244PubMed Prentki M, Renold AE (1983) Neutral amino acid transport in isolated rat pancreatic islets. J Biol Chem 258:14239–14244PubMed
12.
go back to reference Gao Z-Y, Li G, Najafi H, Wolf BA, Matschinski FM (1999): Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes 48:1535–1542PubMed Gao Z-Y, Li G, Najafi H, Wolf BA, Matschinski FM (1999): Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes 48:1535–1542PubMed
13.
go back to reference Malaisse WJ, Sener A, Malaisse-Lagae F et al. (1982) The stimulus-secretion coupling of amino acid-induced insulin release: metabolic response of pancreatic islets of L-glutamine and L-leucine. J Biol Chem 257:8731–8737PubMed Malaisse WJ, Sener A, Malaisse-Lagae F et al. (1982) The stimulus-secretion coupling of amino acid-induced insulin release: metabolic response of pancreatic islets of L-glutamine and L-leucine. J Biol Chem 257:8731–8737PubMed
14.
go back to reference Stanley CA, Lieu YK, Hsu BY et al. (1998) Hyperinulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357 Stanley CA, Lieu YK, Hsu BY et al. (1998) Hyperinulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357
15.
go back to reference Stanley CA, Fang J, Kutyna K et al. (2000) Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. Diabetes 49:667–673PubMed Stanley CA, Fang J, Kutyna K et al. (2000) Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. Diabetes 49:667–673PubMed
16.
go back to reference MacMullen C, Fang J, Hsu BYL et al. (2001) The Hyperinsulinism/Hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab 86:1782–1787 MacMullen C, Fang J, Hsu BYL et al. (2001) The Hyperinsulinism/Hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab 86:1782–1787
17.
go back to reference Tanizawa Y, Nakai K, Sasaki T et al. (2002) Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimultaed insulin secretion- identification and characterization of a GLUD1 gene mutation and insulin secretion studies with MIN6 cells overexpressing the mutant glutamate dehydrogenase. Diabetes 51:712–717PubMed Tanizawa Y, Nakai K, Sasaki T et al. (2002) Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimultaed insulin secretion- identification and characterization of a GLUD1 gene mutation and insulin secretion studies with MIN6 cells overexpressing the mutant glutamate dehydrogenase. Diabetes 51:712–717PubMed
18.
go back to reference Rubi B, Ishihara H, Hegardt FG, Wollheim CB, Maechler P (2001) GAD65-mediated glutamate decarboxylation reduces glucose-stimulated insulin secretion in pancreatic beta cells. J Biol Chem 276:36391–36396CrossRefPubMed Rubi B, Ishihara H, Hegardt FG, Wollheim CB, Maechler P (2001) GAD65-mediated glutamate decarboxylation reduces glucose-stimulated insulin secretion in pancreatic beta cells. J Biol Chem 276:36391–36396CrossRefPubMed
19.
go back to reference Hellman B, Sehlin J, Taljedal IB (1971) Uptake of alanine, arginine and leucine by mammalian pancreatic β-cells. Endocrinology 89:1432–1439PubMed Hellman B, Sehlin J, Taljedal IB (1971) Uptake of alanine, arginine and leucine by mammalian pancreatic β-cells. Endocrinology 89:1432–1439PubMed
20.
go back to reference Michalik M, Nelson J, Erecinska M (1992) Glutamate production in islets of Langerhans: properties of phosphate-activated glutaminase. Metabolism 41:1319–1326PubMed Michalik M, Nelson J, Erecinska M (1992) Glutamate production in islets of Langerhans: properties of phosphate-activated glutaminase. Metabolism 41:1319–1326PubMed
21.
go back to reference Curthoys NP, Watford M (1995) Regulation of glutaminase activity and glutamine metabolism. Ann Rev Nutr 15:133–159CrossRef Curthoys NP, Watford M (1995) Regulation of glutaminase activity and glutamine metabolism. Ann Rev Nutr 15:133–159CrossRef
22.
go back to reference Nissim I, States B, Nissim I, Yudkoff M (1991) The role of γ-glutamyl transpeptidase in glutamine metabolism by cultured human kidney cells. Contrib Nephrol 92:191–192PubMed Nissim I, States B, Nissim I, Yudkoff M (1991) The role of γ-glutamyl transpeptidase in glutamine metabolism by cultured human kidney cells. Contrib Nephrol 92:191–192PubMed
23.
go back to reference Anjaneyulu K, Anjaneyulu R, Senner A, Malaisse WJ (1981) γ-glutamyltranspeptidase activity in pancreatic islets. FEBS Lett 125:57–59CrossRefPubMed Anjaneyulu K, Anjaneyulu R, Senner A, Malaisse WJ (1981) γ-glutamyltranspeptidase activity in pancreatic islets. FEBS Lett 125:57–59CrossRefPubMed
24.
go back to reference Brennan L, Shine A, Hewage C et al. (2002) A NMR based demonstration of substantial oxidative L-alanine metabolism and L-alanine enhanced glucose metabolism in a clonal pancreatic β-cell line-metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51:1714–1721PubMed Brennan L, Shine A, Hewage C et al. (2002) A NMR based demonstration of substantial oxidative L-alanine metabolism and L-alanine enhanced glucose metabolism in a clonal pancreatic β-cell line-metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51:1714–1721PubMed
25.
go back to reference Ammon HPT, Grimm A, Lutz S, Wagner-Teschner D, Händel M, Hagenloh I (1980) Islet glutathione and insulin release. Diabetes 29:830–834PubMed Ammon HPT, Grimm A, Lutz S, Wagner-Teschner D, Händel M, Hagenloh I (1980) Islet glutathione and insulin release. Diabetes 29:830–834PubMed
26.
go back to reference McClenaghan NH, Flatt PR (1999) Engineering cultures insulin-secreting pancreatic β-cell lines. J Mol Med 77:235–243CrossRefPubMed McClenaghan NH, Flatt PR (1999) Engineering cultures insulin-secreting pancreatic β-cell lines. J Mol Med 77:235–243CrossRefPubMed
27.
go back to reference McClenaghan NH, Barnett CR, Ah-Sing E et al. (1996) Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-DB11, produced by electrofusion. Diabetes 45:1132–1140PubMed McClenaghan NH, Barnett CR, Ah-Sing E et al. (1996) Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-DB11, produced by electrofusion. Diabetes 45:1132–1140PubMed
28.
go back to reference O'Harte FPM, Mooney MH, Flatt PR (1999) N-terminally glycated gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced anti-hyperglycemic activity. Diabetes 48:758–765PubMed O'Harte FPM, Mooney MH, Flatt PR (1999) N-terminally glycated gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced anti-hyperglycemic activity. Diabetes 48:758–765PubMed
29.
go back to reference Chapman JC, McClenaghan NH, Cosgrove KE et al. (1999) ATP-sensitive potassium channels and efaroxan-induced insulin release in the elctrofusion-derived BRIN-BD11 beta-cell line. Diabetes 48:2349–2357PubMed Chapman JC, McClenaghan NH, Cosgrove KE et al. (1999) ATP-sensitive potassium channels and efaroxan-induced insulin release in the elctrofusion-derived BRIN-BD11 beta-cell line. Diabetes 48:2349–2357PubMed
30.
go back to reference Saldago, AP, Santos RM, Fernandez AP, Tome AR, Flatt PR, Rosario LM (2000) Glucose-mediated Ca2+ signalling in clonal insulin-secreting BRIN-BD11 cells: evidence for mixed model of cellular activation. Int J Biochem Cell Biol 32:557–569CrossRefPubMed Saldago, AP, Santos RM, Fernandez AP, Tome AR, Flatt PR, Rosario LM (2000) Glucose-mediated Ca2+ signalling in clonal insulin-secreting BRIN-BD11 cells: evidence for mixed model of cellular activation. Int J Biochem Cell Biol 32:557–569CrossRefPubMed
31.
go back to reference Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275
32.
go back to reference Finucane MD, Hudson EA, Malthouse JPG (1989) A13C-NMR investigation of the ionizations within an inhibitor-alpha-chymotrypsin complex. Evidence that both alpha-chymotrypsin and trypsin stabilize a hemiketal oxyanion by similar mechanisms. Biochem J 258:853–859PubMed Finucane MD, Hudson EA, Malthouse JPG (1989) A13C-NMR investigation of the ionizations within an inhibitor-alpha-chymotrypsin complex. Evidence that both alpha-chymotrypsin and trypsin stabilize a hemiketal oxyanion by similar mechanisms. Biochem J 258:853–859PubMed
33.
go back to reference Fan TWM (1996) Metabolite profiling by one- and two- dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc 28:161–219CrossRef Fan TWM (1996) Metabolite profiling by one- and two- dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc 28:161–219CrossRef
34.
go back to reference Chateil JF, Biran M, Thiaudière E, Canioni P, Merle M (2001) Metabolism of [1-13C]glucose and [2-13C]acetate in the hypoxic rat brain. Neurochem Int 38:399–407CrossRefPubMed Chateil JF, Biran M, Thiaudière E, Canioni P, Merle M (2001) Metabolism of [1-13C]glucose and [2-13C]acetate in the hypoxic rat brain. Neurochem Int 38:399–407CrossRefPubMed
35.
go back to reference Windmueller HG, Spaeth AE (1974): Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 249:5070–5079PubMed Windmueller HG, Spaeth AE (1974): Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 249:5070–5079PubMed
36.
go back to reference Richman PG, Orlowski M, Meister A (1973) Inhibition of γ-glutamylcysteine synthetase by L-methionine-S-sulfoximine. J Biol Chem 248:6684–6690PubMed Richman PG, Orlowski M, Meister A (1973) Inhibition of γ-glutamylcysteine synthetase by L-methionine-S-sulfoximine. J Biol Chem 248:6684–6690PubMed
37.
go back to reference Watson RWG, Rotstein OD, Nathens AB, Dackiw APB, Marshall JC (1996) Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 120:150–158PubMed Watson RWG, Rotstein OD, Nathens AB, Dackiw APB, Marshall JC (1996) Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 120:150–158PubMed
38.
go back to reference Macho A, Hirsch T, Marzo I et al. (1997) Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol 158:4612–4619PubMed Macho A, Hirsch T, Marzo I et al. (1997) Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol 158:4612–4619PubMed
39.
go back to reference Tiedge M, Lortz S, Munday R, Lenzen S (1999) Protection against the cooperative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849–855PubMed Tiedge M, Lortz S, Munday R, Lenzen S (1999) Protection against the cooperative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849–855PubMed
40.
go back to reference Tiedge M, Lortz S, Munday R, Lenzen S (1998) Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578–1585PubMed Tiedge M, Lortz S, Munday R, Lenzen S (1998) Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578–1585PubMed
41.
go back to reference Bolanos JP, Heales SJ, Peuchen S, Barker JE, Land JM, Clark JB (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med 21:995–1001CrossRefPubMed Bolanos JP, Heales SJ, Peuchen S, Barker JE, Land JM, Clark JB (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med 21:995–1001CrossRefPubMed
42.
go back to reference O'Neill A, O'Neill S, Hegarty NJ et al. (2000) Glutathione depletion-induced neutrophil apoptosis is caspase-3 dependent. Shock 14:605–609PubMed O'Neill A, O'Neill S, Hegarty NJ et al. (2000) Glutathione depletion-induced neutrophil apoptosis is caspase-3 dependent. Shock 14:605–609PubMed
43.
go back to reference Malaisse WJ, Dufrane SP, Mathias PCF et al. (1985) The coupling of metabolic to secretory events in pancreatic islets. The possible role of glutathione reductase. Biochim Biophys Acta: 844:256–264 Malaisse WJ, Dufrane SP, Mathias PCF et al. (1985) The coupling of metabolic to secretory events in pancreatic islets. The possible role of glutathione reductase. Biochim Biophys Acta: 844:256–264
44.
go back to reference Kondo H, Mori S, Takino H et al. (2000) Attenuation of expression of γ-glutamylcycteine synthetase by ribozyme transfection enhance insulin secretion by pancreatic β cell line, MIN6. Biochem Biophys Res Comm 278:236–240CrossRefPubMed Kondo H, Mori S, Takino H et al. (2000) Attenuation of expression of γ-glutamylcycteine synthetase by ribozyme transfection enhance insulin secretion by pancreatic β cell line, MIN6. Biochem Biophys Res Comm 278:236–240CrossRefPubMed
45.
go back to reference Salehi A, Parandeh F, Lundquist I (1998) Signal transduction in islet hormone release: interaction of nitric oxide with basal and nutrient-induced hormone responses. Cell Signal 10:645–651CrossRefPubMed Salehi A, Parandeh F, Lundquist I (1998) Signal transduction in islet hormone release: interaction of nitric oxide with basal and nutrient-induced hormone responses. Cell Signal 10:645–651CrossRefPubMed
46.
go back to reference Clementi E, Brown GC, Feelisch M, Moncada S (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95:7631–7636CrossRefPubMed Clementi E, Brown GC, Feelisch M, Moncada S (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95:7631–7636CrossRefPubMed
47.
go back to reference DiPietrantonin AM, Hsieh T, Wu JM (1999) Activation of caspase 3 in HL-60 cells exposed to hydrogen peroxide. Biochem Biophys Res Commun 255:477–482CrossRefPubMed DiPietrantonin AM, Hsieh T, Wu JM (1999) Activation of caspase 3 in HL-60 cells exposed to hydrogen peroxide. Biochem Biophys Res Commun 255:477–482CrossRefPubMed
48.
go back to reference Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE (1998) Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc Natl Acad Sci USA 95:2956–2960CrossRefPubMed Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE (1998) Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc Natl Acad Sci USA 95:2956–2960CrossRefPubMed
49.
go back to reference Sener A, Malaisse WJ (1980) L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288:187–189PubMed Sener A, Malaisse WJ (1980) L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288:187–189PubMed
50.
go back to reference MacDonald MJ, McKenzie DI, Kaysen JH et al. (1991) Glucose regulates leucine-induced insulin release and the expression of the branched-chain ketoacid dehydrogenase E1a subunit gene in pancreatic islets. J Biol Chem 266:1335–1340PubMed MacDonald MJ, McKenzie DI, Kaysen JH et al. (1991) Glucose regulates leucine-induced insulin release and the expression of the branched-chain ketoacid dehydrogenase E1a subunit gene in pancreatic islets. J Biol Chem 266:1335–1340PubMed
Metadata
Title
13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and γ-glutamyl cycle activity in a clonal pancreatic beta-cell line
Authors
L. Brennan
M. Corless
C. Hewage
J. P. G. Malthouse
N. H. McClenaghan
P. R. Flatt
P. Newsholme
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1184-7

Other articles of this Issue 11/2003

Diabetologia 11/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine